Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned...
ORNL researchers develop AI based tool to match cancer patients with clinical trials
A team of researchers from the Department of Energy’s (DOE) Oak Ridge National Laboratory (ORNL) Health Data Sciences Institute in the US has developed an artificial intelligence (AI) based digital tool for matching cancer patients with clinical trials.
Embleema, Gustave Roussy to develop blockchain-based applications for cancer research
Embleema has partnered with Gustave Roussy Institut to develop blockchain-based health data sharing applications to accelerate cancer research.
Analysis finds increasing early-stage trials for rare cancers
A new analysis by the National Cancer Center Hospital in Japan has found that the focus of early-stage clinical trials is shifting from major cancer killers to rare types of tumours.
Industry Viewpoints: Patient Recruitment and Expanded Access
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges of patient recruitment
Expert Insights: EMA Reinforces Stance on Biosimilar Use for Sustainable Health Care in New Educational Video
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the importance of the EMA’s efforts to improve patient and physician education on biosimilar medicines